LST8 negatively regulates amino acid biosynthesis as a component of the TOR pathway by Chen, Esther J. & Kaiser, Chris A.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 

 
 The Rockefeller University Press, 0021-9525/2003/04/333/15 $8.00
The Journal of Cell Biology, Volume 161, Number 2, April 28, 2003 333–347
http://www.jcb.org/cgi/doi/10.1083/jcb.200210141
 
JCB
 
Article
 
333
 
LST8
 
 negatively regulates amino acid biosynthesis as a 
component of the TOR pathway
 
Esther J. Chen and Chris A. Kaiser
 
Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139
 
ST8
 
, a 
 
Saccharomyces cerevisiae
 
 gene encoding a
34-kD WD-repeat protein, was identiﬁed by mutations
that caused defects in sorting Gap1p to the plasma
membrane. Here, we report that the Gap1p sorting defect
in the 
 
lst8-1
 
 mutant results from derepression of Rtg1/3p
activity and the subsequent accumulation of high levels of
intracellular amino acids, which signal Gap1p sorting to
the vacuole. To identify the essential function of Lst8p, we
isolated 
 
lst8
 
 mutants that are temperature-sensitive for
growth. These mutants show hypersensitivity to rapamycin
and derepressed Gln3p activity like cells with compromised
TOR pathway activity. Like 
 
tor2
 
 mutants, 
 
lst8
 
 mutants also
L
 
have cell wall integrity defects. Conﬁrming a role for
Lst8p in the TOR pathway, we ﬁnd that Lst8p associates
with both Tor1p and Tor2p and is a peripheral membrane
protein that localizes to endosomal or Golgi membranes
and cofractionates with Tor1p. Further, we show that a sub-
lethal concentration of rapamycin mimics the Gap1p
sorting defect of an 
 
lst8
 
 mutant. Finally, the different effects
of 
 
lst8
 
 alleles on the activation of either the Rtg1/3p or
Gln3p transcription factors reveal that these two pathways
constitute distinct, genetically separable outputs of the
Tor–Lst8 regulatory complex.
 
Introduction
 
The general amino acid permease Gap1p of 
 
Saccharomyces
cerevisiae
 
 is a high-capacity permease that can transport all
amino acids (Grenson et al., 1970; Jauniaux and Grenson,
1990). The nitrogen source in the growth medium regulates
Gap1p activity both transcriptionally and post-transcriptionally
(Magasanik and Kaiser, 2002). Growth on rich nitrogen
sources such as glutamine or yeast extract/peptone/dextrose
(YPD)* represses 
 
GAP1
 
 transcription, whereas nitrogen star-
vation or growth on poor nitrogen sources induces 
 
GAP1
 
transcription.
The nitrogen source in the growth medium also regulates
the intracellular sorting of Gap1p. When cells are grown on
glutamate or when Gap1p is artificially expressed during
growth on glutamine, Gap1p is sorted to the vacuole and
Gap1p activity at the plasma membrane is very low. Con-
versely, during growth on the nitrogen sources urea, proline,
or ammonia (in the S288C background), Gap1p is sorted to
the plasma membrane and Gap1p activity at the plasma
membrane is high (Stanbrough and Magasanik, 1995; Roberg
et al., 1997b; Chen and Kaiser, 2002). Gap1p sorting is
thought to be largely regulated at the endosome or trans-Golgi
stages of the secretory and endosomal trafficking pathways
(Roberg et al., 1997b; Helliwell et al., 2001).
Mutations that alter Gap1p sorting can be broadly divided
into two classes: mutations that affect Gap1p trafficking,
and mutations that affect the production of the sorting signal
(Magasanik and Kaiser, 2002). The first class of mutations
resides mainly in genes involved in ubiquitination, such as
 
BUL1
 
, 
 
BUL2
 
, 
 
RSP5
 
, and 
 
DOA4
 
. Apparently, polyubiquitina-
tion of Gap1p is required for its sorting to the vacuole.
Thus, mutations that interfere with the polyubiquitination
of Gap1p cause high Gap1p activity and increased sorting of
Gap1p to the plasma membrane (Helliwell et al., 2001; Soetens
et al., 2001; Springael et al., 2002).
The second class of mutations that affect Gap1p sorting
resides in genes that influence the net amount of amino acid
biosynthesis, such as 
 
GDH1
 
, 
 
GLN1
 
, and 
 
MKS1
 
 (Chen and
Kaiser, 2002). Yeast uses glutamate and glutamine as the
nitrogen donors to synthesize all other amino acids (Magasanik,
1992). Thus, mutations that affect the rate of glutamate and
glutamine synthesis also affect the net synthesis of all amino
acids, and therefore affect Gap1p sorting. 
 
GDH1
 
 encodes the
anabolic glutamate dehydrogenase, the primary enzyme respon-
sible for glutamate synthesis during growth on ammonia
medium (Grenson et al., 1974). 
 
GLN1
 
 encodes glutamine
synthetase, an essential gene for growth on medium lacking
glutamine (Mitchell, 1985). Deletion of 
 
GDH1
 
 or mutation
 
Address correspondence to Chris A. Kaiser 68-533, Dept. of Biology,
Massachusetts Institute of Technology, 77 Massachusetts Ave., Cambridge,
MA 02139. Tel.: (617) 253-9804. Fax: (617) 253-6622. 
E-mail: ckaiser@mit.edu
*Abbreviation used in this paper: YPD, yeast extract/peptone/dextrose.
Key words: 
 
GAP1
 
; rapamycin; 
 
GLN3
 
; Golgi; RTG1T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
334 The Journal of Cell Biology 
 
|
 
 
 
Volume 161, Number 2, 2003
 
of 
 
GLN1
 
 causes a decrease in cellular glutamate and/or
glutamine content and an increase in sorting of Gap1p to the
plasma membrane relative to wild type. Mutation of 
 
MKS1
 
has the opposite effect. 
 
MKS1
 
 encodes a negative regulator of
the Rtg1/3p transcription factors that control the expression
of the TCA cycle enzymes responsible for 
 
 
 
-ketoglutarate
synthesis during growth on medium with glucose (Liu and
Butow, 1999; Dilova et al., 2002; Sekito et al., 2002; Tate et
al., 2002). Because 
 
 
 
-ketoglutarate forms the carbon skeleton
from which glutamate and glutamine are derived, 
 
MKS1
 
 has a
net negative effect on glutamate and glutamine synthesis.
Thus, an 
 
mks1
 
 
 
 mutant shows high intracellular amino acid
levels and decreased sorting of Gap1p to the plasma mem-
brane (Chen and Kaiser, 2002).
One of the first mutants with a defect in Gap1p traffick-
ing that we isolated was the 
 
lst8-1
 
 mutant. The 
 
lst8-1
 
 mu-
Figure 1. The Gap1p sorting defect of an lst8-1 
mutant is suppressed by deletion of gdh1. 
(A) Gap1p activity was measured by assaying 
the rate of [
14C]citrulline uptake (white bars) of 
wild-type (CKY759), lst8-1 (CKY768), gdh1  
(CKY762), or lst8-1 gdh1  (CKY769), all with the 
GAP1 locus replaced by PADH1-GAP1-HA, or of 
gap1  (CKY445) growing on ammonia medium. 
The rate of [
14C]arginine uptake (gray bars) is 
shown for comparison. Uptake rates are expressed 
as a percentage of the uptake rate of wild-type. The 
data shown represent three independent assays, 
and the error bars represent one SD. (B) The first 
four strains shown in A were grown in ammonia 
medium at 24 C, and cell extracts were subjected 
to isopycnic fractionation on continuous 20–60% 
sucrose density gradients with EDTA. Fractions 
were collected from the top of the gradients and 
proteins were separated by SDS-PAGE. In all the 
strains shown, Pma1p, Dpm1p, and GDPase 
fractionated similarly.T
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tant was shown to greatly diminish sorting of Gap1p to the
plasma membrane in cells grown on ammonia or urea as a
nitrogen source (Roberg et al., 1997a). 
 
LST8
 
 encodes an es-
sential protein with WD-repeats and has a closely related
human orthologue. A recent report from the Butow lab
showed that Lst8p was involved in the negative regulation of
the Rtg1/3p transcription factors (Liu et al., 2001). The 
 
lst8
 
mutants they isolated were shown to have elevated 
 
CIT2
 
transcription and decreased sensitivity to glutamate for
 
CIT2
 
 repression (Liu et al., 2001). These findings suggested
that either Lst8p has an indirect effect on Gap1p sorting,
like Mks1p, or that Lst8p has at least two separate functions:
one function in the regulation of Rtg1/3p, and another
function in the regulation of permease sorting.
Recently, Hall and colleagues reported that Lst8p was as-
sociated with Tor1p and with Tor2p. Tor1p coimmunopre-
cipitated with Kog1p and Lst8p, and Tor2p coimmunopre-
cipitated with Kog1p, Lst8p, Avo1p, Avo2p, and Avo3p.
These coimmunoprecipitation studies, supplemented by
depletion assays with genes under the control of glucose-
repressible promoters, led Hall and colleagues to propose
that Lst8p associates with the Tor proteins in the TORC1
and TORC2 complexes, which may have distinct roles in
growth control (Loewith et al., 2002).
Here, we investigate the role of Lst8p in Gap1p permease
sorting and find that the effects of 
 
lst8
 
 mutations on Gap1p
sorting are an indirect consequence of increased intracellular
amino acid levels in 
 
lst8
 
 mutants. We characterize the phe-
notypes of 
 
lst8
 
 mutants and present evidence that Lst8p is a
positively acting component of Tor-containing complexes.
 
Results
 
The effect of 
 
lst8-1
 
 on Gap1p sorting is indirect
 
An 
 
lst8-1
 
 mutation causes Gap1p to be sorted to the vacuole
under growth conditions in which Gap1p is normally sorted
to the plasma membrane (Roberg et al., 1997a). Because
Gap1p is both transcriptionally and post-transcriptionally
regulated by the nitrogen source in the growth medium, we
verified that the primary effect of 
 
lst8-1
 
 on Gap1p activity
was an effect on Gap1p sorting, using a 
 
P
 
ADH1
 
-HA-GAP1
construct that renders 
 
GAP1
 
 transcription insensitive to ni-
trogen source quality (Chen and Kaiser, 2002). Indeed, an
 
lst8-1
 
 mutant with 
 
P
 
ADH1
 
-HA-GAP1 had no detectable
Gap1p activity as measured by uptake of [
 
14
 
C]citrulline,
which is transported exclusively by Gap1p (Fig. 1 A), and no
 
Gap1p localized to the plasma membrane (Fig. 1 B). Uptake
of [
 
14
 
C]arginine, which is transported by Gap1p and by the
arginine permease Can1p, is similar in the 
 
lst8-1
 
 and 
 
gap1
 
 
 
mutants, indicating that the effect of 
 
lst8-1
 
 on permease
sorting is specific for Gap1p, and is not the result of a gen-
eral decrease in all permease activity (Fig. 1 A).
Butow and colleagues recently reported that Lst8p nega-
tively regulates the Rtg1p and Rtg3p transcription factors,
which control the transcription of genes responsible for
 
 
 
-ketoglutarate synthesis during growth on medium with
glucose (Liu et al., 2001). Glutamate and glutamine nor-
mally repress Rtg1/3p activity in a negative feedback loop
required for proper amino acid homeostasis because 
 
 
 
-keto-
glutarate is the precursor of glutamate and glutamine, the
two amino acids from which the cell synthesizes all the
other amino acids (Magasanik, 1992; Liu and Butow, 1999;
Komeili et al., 2000). Deletion of 
 
MKS1
 
, another negative
regulator of Rtg1/3p, has been shown to result in elevated
intracellular levels of 
 
 
 
-ketoglutarate, glutamate, and total
amino acids, and as a consequence leads to decreased
sorting of Gap1p to the plasma membrane (Feller et al.,
1997; Chen and Kaiser, 2002). To determine if the 
 
lst8-1
 
mutation had an effect similar to 
 
mks1
 
 
 
 on cellular amino
acid content, we performed whole-cell amino acid analysis
and found that 
 
lst8-1
 
, like 
 
mks1
 
 
 
, had 
 
 
 
1.5–2.5-fold
higher intracellular levels of glutamate and total amino ac-
ids than wild-type cells (Table I).
If an 
 
lst8-1
 
 mutation causes a Gap1p sorting defect indi-
rectly by de-repressing Rtg1/3p and increasing cellular
glutamate levels, then the elimination of 
 
GDH1,
 
 which en-
codes the major enzyme for the synthesis of glutamate from
 
 
 
-ketoglutarate on ammonia medium (Grenson et al.,
1974), should significantly diminish the Gap1p sorting de-
fect of an 
 
lst8-1
 
 mutant. We found that the 
 
lst8-1 gdh1
 
 
 
double mutant had 30% of wild-type Gap1p activity, com-
pared with 
 
 
 
1% for the 
 
lst8-1
 
 mutant alone during growth
on ammonia (Fig. 1 A). The 
 
lst8-1 gdh1
 
 
 
 double mutant
also showed more Gap1p sorted to the plasma membrane
than an 
 
lst8-1
 
 mutant (Fig. 1 B). Together with the amino
acid analysis of 
 
lst8-1
 
, these data suggested that the Gap1p
sorting defect was an indirect consequence of the increased
amino acid levels in the 
 
lst8-1
 
 mutant.
 
Identification of temperature-sensitive 
 
lst8
 
 mutations
 
LST8
 
 is an essential gene, and we generated conditional al-
leles to investigate the essential function of 
 
LST8
 
. The 
 
lst8-6
 
Table I. 
 
Total amino acid content of strains relative to wild type
Amino acid content (normalized to WT)
Glt Gln Glt 
 
 
 
 Gln Total amino acids
 
WT 1.0 1.0 1.0 1.0
 
lst8-1
 
2.4 
 
 
 
 0.1 1.9 
 
 
 
 0.1 2.1 
 
 
 
 0.1 1.7 
 
 
 
 0.1
 
mks1
 
 
 
2.4 
 
 
 
 0.2 1.3 
 
 
 
 0.1 1.8 
 
 
 
 0.1 1.5 
 
 
 
 0.1
WT 
 
  
 
5 ng/ml rapamycin 2.5 
 
 
 
 0.3 4.5 
 
 
 
 0.1 6.6 
 
  0.0 2.6   0.0
Amino acid contents of lst8-1 and mks1  and WT   rap samples are expressed relative to a wild-type amino acid content of 1. Absolute values of WT amino
acid content (no drug) are as follows (nmol/OD600): Glt, 22.3   4.6; Gln, 33.1   6.8; Glt   Gln, 55.3   10.3; and Total, 134.6   26.4. This experiment
was performed four times with lst8-1 and twice with mks1  and WT   5 ng/ml rapamycin. Wild-type (CKY443), lst8-1 (CKY526), and mks1  (CKY758) were
grown to exponential phase on minimal ammonia media at 24 C. In addition, wild-type was grown in the same medium containing 5 ng/ml rapamycin.T
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and lst8-7 temperature-sensitive alleles were generated by hy-
droxylamine and PCR mutagenesis, respectively, and inte-
grated at the LST8 locus. The lst8-6 mutant failed to grow at
temperatures above 34 C, whereas lst8-7 failed to grow above
37 C on YPD medium. Like lst8-1, both lst8-6 and lst8-7
had low Gap1p activity at the plasma membrane during
growth on ammonia medium at 24 C (unpublished data).
We first checked lst8-6 and lst8-7 for derepressed Rtg1/3p
activity by using a PCIT2-LacZ reporter. Rtg1/3p activity is
normally repressed in the presence of glutamate, but has been
reported to be derepressed in several different lst8 mutants
grown in YPD or in medium with casamino acids (Liu et al.,
2001). We found that lst8-6 and lst8-7 had strongly dere-
pressed  PCIT2-LacZ expression during growth on glutamate
medium (Table II). Consistent with previous reports, we
found that the lst8-1 allele showed little Rtg1/3p derepression,
and that overall the lst8 mutants had a more modest effect on
Rtg1/3p derepression on glutamate medium than mks1  (Liu
et al., 2001; Sekito et al., 2002). The lst8-6 and lst8-7 mutants
were able to suppress rtg2  somewhat with regard to PCIT2-
LacZ activity, though suppression was not complete as in the
case of mks1  (Table II; Liu et al., 2001; Sekito et al., 2002).
Also,  lst8-6 and lst8-7  (but not lst8-1) complemented the
glutamate auxotrophy of rtg2  (unpublished data).
We looked for a link between Lst8p function and the activity
of the TOR pathway by testing the sensitivity of lst8 mutants to
rapamycin. Like Lst8p and Mks1p, the TOR pathway nega-
tively regulates Rtg1/3p, as shown by the ability of the TOR in-
hibitor rapamycin to induce the expression of Rtg1/3p-depen-
dent genes in strains grown on glutamate or glutamine (Komeili
et al., 2000). At the semi-permissive temperature of 30 C on
rich medium, lst8 mutants were hypersensitive to rapamycin
(Fig. 2), like a tor1  mutant that was previously shown to be ra-
pamycin hypersensitive (Chan et al., 2000), indicating that
Lst8p might function positively in the TOR pathway.
lst8 mutations derepress the Gln3p transcription factor
A well-studied effect of rapamycin in yeast is its ability to
produce effects on the global pattern of gene expression sim-
Table II. Mutations in lst8 cause derepression of
Rtg1/3p-dependent transcription
Strain
PCIT2-LacZ expression 
on glutamate medium Standard deviation
( -galactosidase units) ( -galactosidase units)
WT 2.4 0.6
lst8-1 9.3 4.1
lst8-6 251.3 10.7
lst8-7 83.9 8.8
mks1  729.1 39.7
ure2  4.2 1.5
rtg2  0.8 0.1
rtg2  lst8-1 1.4 0.8
rtg2  lst8-6 147.8 13.9
rtg2  lst8-7 33.7 2.4
rtg2  mks1  752.4 80.4
Strains were ura3-52 (CKY772), lst8-1 ura3-52 (CKY773), lst8-6 ura3-52
(CKY774), lst8-7 ura3-52 (CKY775), mks1  ura3-52 (CKY776), ure2  ura3-
52 (CKY777), rtg2   ura3-52 (CKY795), rtg2   lst8-1 ura3-52 (CKY796),
rtg2  lst8-6 ura3-52 (CKY797), rtg2  lst8-7 ura3-52 (CKY798), and rtg2 
mks1  ura3-52 (CKY799) containing pEC261.
Figure 2. Mutations in lst8 confer rapamycin hypersensitivity. Wild-type (CKY443), lst8-1 (CKY526), lst8-6 (CKY770), lst8-7 (CKY771), 
tor1  (Euroscarf), and gln3  (CKY778) were streaked onto YPD or YPD   200 ng/ml rapamycin and incubated at 30 C for 2 or 4 d, respectively. 
The tor1  strain is included as a control for a rapamycin-hypersensitive strain, and the gln3  strain is included as an example of a rapamycin-
resistant strain.
Table III. Mutations in lst8 cause increased
Gln3p-dependent transcription
Strain
PGAP1-LacZ expression 
in glutamine medium Standard deviation
( -galactosidase units) ( -galactosidase units)
WT 12.7 0.4
lst8-1 35.9 5.8
lst8-6 14.6 1.5
lst8-7 31.3 2.5
mks1  0.4 0.1
ure2  361.4 78.9
tor1  24.6 6.0
WT   200 ng/ml 
rap (1 h)
25.1 1.5
WT   200 ng/ml 
rap (2 h)
82.2 2.3
Strains were as listed in Table II and tor1  ura3-52 (CKY794), containing
pMS29.T
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ilar to those of nitrogen starvation (Cardenas et al., 1999;
Hardwick et al., 1999). Rapamycin treatment induces the
transcription of nitrogen-regulated genes such as GAP1 that
are normally repressed by good nitrogen sources. We ex-
amined PGAP1-LacZ expression in lst8 mutants grown in
glutamine medium, which strongly represses GAP1 tran-
scription in wild-type cells. GAP1 expression was dere-
pressed 2.5–3-fold in lst8-1 and lst8-7 mutants growing on
glutamine (Table III). In comparison, wild-type cells treated
with rapamycin for 1 h and tor1  showed a twofold increase
in PGAP1-LacZ activity, and wild-type cells treated with rapa-
mycin for 2 h showed a 6.5-fold increase in PGAP1-LacZ ac-
tivity. In a ure2  mutant in which the negative regulation of
the Gln3p transcription factor by glutamine has been com-
pletely abolished, GAP1 expression was derepressed  30-
fold (Table III). Unlike the mks1  and ure2  mutations,
which exclusively derepress either Rtg1/3p activity or Gln3p
activity, respectively, lst8 mutants derepress both Rtg1/3p
and Gln3p regulation (Table II and Table III). This result
further suggested that LST8 might function in the TOR
pathway because the TOR pathway influences both Rtg1/3p
and Gln3p regulation.
Derepression of GAP1 transcription by rapamycin treat-
ment has been shown to be accompanied by relocalization
of the GATA-type transcription factor Gln3p from the cy-
toplasm to the nucleus (Beck and Hall, 1999). By immu-
nofluorescence we found that, like rapamycin treatment of
wild-type cells, mutation of lst8 caused the inappropriate
nuclear localization of Gln3p-myc in many cells growing in
glutamine medium (Fig. 3). In our strain background grow-
ing on glutamine, we found that rapamycin treatment for
30 min caused nuclear localization in 28% of the cells,
whereas the lst8-7 and lst8-1 mutations resulted in the nu-
clear localization of Gln3p in 8–19% of the cells (Table
IV). Deletion of gln3 has been shown to confer rapamycin
resistance (Chan et al., 2000). We found that deletion of
gln3 could partially rescue the temperature-sensitive growth
defect of lst8-7 (Fig. 4). Together, these data show that mu-
tation of lst8 produces effects similar to those observed on
rapamycin treatment.
Figure 3. Mutations in lst8 cause nuclear 
localization of Gln3p during growth on glutamine. 
Wild-type (CKY779), lst8-7 (CKY781), and lst8-1 
(CKY780), all with integrated GLN3-myc, were 
grown in glutamine medium at 24 C. Rapamycin 
was added to the indicated sample for 30 min, and 
one lst8-7 sample was incubated at 37 C for 2 h 
before fixation of cells for immunofluorescence. 
All images are shown at the same magnification.T
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nication). HA-tagged versions of Tor1p and Tor2p were
reported to be functional (Fiorentino and Crabtree, 1997;
Kunz et al., 2000), and we verified the function of our
constructs by complementation of the rapamycin sensitiv-
ity of a tor1  strain (for HA-TOR1) and complementation
of the lethality of a tor2  strain (for HA-TOR2; unpub-
lished data). We expressed HA-TOR1 or HA-TOR2 from
their own promoters on CEN vectors in strains with LST8-
6xmyc integrated at the LST8 locus. Using myc antibody to
precipitate Lst8p-myc–containing complexes and immu-
noblots to detect HA-Tor1p or HA-Tor2p, we found that
HA-Tor1p and HA-Tor2p are present in complex with
Lst8p-myc (Fig. 6). We also looked at the dependence of
this interaction on the nitrogen source, but found that the
association of HA-Tor1p and HA-Tor2p with Lst8p-myc
is not significantly influenced by growth in nitrogen-free
medium or in YPD with 0.3% glutamine (unpublished
data). Together with the lst8 mutant phenotypes, this re-
sult indicates that Lst8p physically associates with Tor1p
and Tor2p to effect TOR pathway function.
Partial inactivation of TOR function results in low 
Gap1p activity
The data presented thus far lead to the prediction that a par-
tial inactivation of the TOR pathway, like mutation of lst8,
should lead to an increase in cellular amino acid pools and a
decrease in the amount of Gap1p sorted to the plasma mem-
brane. However, we showed recently that inhibition of Tor
by the lethal concentration of rapamycin that is routinely
used to arrest cell growth, halt translation initiation, and in-
duce rapamycin-sensitive genes fails to signal nitrogen star-
vation to the Gap1p sorting machinery; the addition of 200
ng/ml rapamycin to rich medium failed to increase Gap1p
sorting to the plasma membrane in cells with PADH1-HA-
GAP1 (Chen and Kaiser, 2002). It is likely that 200 ng/ml
rapamycin kills cells before cellular amino acid pools have
the opportunity to increase, and a sublethal level of rapamy-
cin might better mimic the effect of an lst8 mutation, allow-
ing amino acid levels to rise, and thus producing a Gap1p
sorting defect.
To test this prediction, we measured Gap1p activity in a
strain containing PADH1-HA-GAP1 grown for 18 h in am-
monia medium with a sublethal concentration of 5 ng/ml
rapamycin. At this low rapamycin concentration, the dou-
bling time is  90% of the doubling time seen in am-
Table IV. Quantitation of lst8 or rapamycin-treated cells with 
Gln3p localized to the nucleus, shown in Fig. 3
Strain Percentage of cells with nuclear Gln3p
WT,  rap 0% (n   625)
WT,  rap 28% (n   621)
lst8-7, 24 C 8% (n   626)
lst8-7, 37 C 11% (n   657)
lst8-1, 24 C 19% (n   626)
Cell wall defects of lst8 mutants
Tor2p has a unique function, not shared with Tor1p, in the
maintenance of the cell wall and actin cytoskeleton (Schmidt
et al., 1996; Bickle et al., 1998; Helliwell et al., 1998). A
tor2 temperature-sensitive mutation is suppressed by growth
of cells on media with osmotic support or with a low con-
centration of detergent, or by mutations in genes that are
important for cell wall integrity such as FKS1 and CWH41,
which encode glucan synthase and glucosidase I, respectively
(Bickle et al., 1998). A possible explanation for this type of
suppression of tor2 alleles is that agents or mutations that
perturb the cell wall may activate a TOR2-independent
pathway for activating Rho1p, leading to a net stabilization
of the cell wall (Bickle et al., 1998).
We found that inclusion of sorbitol in the growth me-
dium fully rescued the temperature sensitivity of lst8-6 and
lst8-7, indicating that these mutations were lethal at high
temperature due to cell lysis (Fig. 5 A). However, inclusion
of sorbitol in the growth medium did not restore growth to
an  lst8  mutant (unpublished data), indicating that the
lst8  mutant fails to grow for reasons other than cell wall in-
stability. We found that SDS in the growth medium or
fks1  or cwh41  mutations could partially suppress the
temperature sensitivity of lst8-6 (Fig. 5, B and C). Together,
these data suggest that Lst8p may also participate with
Tor2p in maintaining cell wall integrity.
Lst8p associates with Tor1p and Tor2p
We tested whether Lst8p associates with Tor1p or Tor2p,
given the evidence presented thus far that mutation of lst8
causes effects similar to the mutation of tor2 and to the in-
activation of TOR pathway function with rapamycin. In
mammalian cells, mLst8 was found to be associated with
mTOR (Kim, D.H., and D.M. Sabatini, personal commu-
Figure 4. Deletion of gln3 suppresses 
the temperature-sensitive growth defect 
of lst8-7. Wild-type (CKY443), gln3  
(CKY778), lst8-7 (CKY771), and lst8-7 
gln3  (CKY782) were spotted onto YPD 
plates and grown at 24 C or 37 C for 3 d.T
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monia medium without rapamycin (unpublished data).
Cells grown in the sublethal concentration of rapamycin
showed 6% of the Gap1p activity of cells without rapamy-
cin (Fig. 7 A), and a corresponding decrease in the
amount of Gap1p localized to the plasma membrane (Fig.
7 B). As with lst8-1, the Gap1p sorting defect caused by
the low level of rapamycin could be partially suppressed
by gdh1  (Fig. 7 A). Furthermore, cells grown in ammo-
nia medium plus 5 ng/ml rapamycin for 18 h showed a
2.6-fold increase in total amino acid content relative to
cells grown without rapamycin (Table I). Thus, like muta-
tion of lst8, impairment of the TOR pathway by growth
with a sublethal rapamycin concentration causes increased
amino acid levels and decreased Gap1p sorting to the
plasma membrane.
Genetically separable effects of lst8 mutants with the 
Rtg1/3 and Gln3 pathways
An examination of the CIT2 and GAP1 reporter assays with
lst8-1 and lst8-6 indicated that lst8-6 had a very strong defect
Figure 5. Inclusion of sorbitol or SDS in the growth medium or deletion of cwh41 or fks1 suppresses the temperature-sensitive growth 
defect of lst8 mutants. (A) Wild-type (CKY443), lst8-6 (CKY770), and lst8-7 (CKY771) were streaked onto YPD or YPD   1 M sorbitol and 
incubated at 37 C for 2 or 3 d, respectively. (B) The same strains as in A were streaked onto YPD or YPD   0.0025% SDS and incubated at 
34 C for 2 d. (C) Wild-type, lst8-6, cwh41  (Euroscarf), fks1  (Euroscarf), lst8-6 cwh41  (CKY786), and lst8-6 fks1  (CKY787) were streaked 
onto YPD and incubated at 24 C or 34 C for 3 or 2 d, respectively.T
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in Rtg1/3p but not in Gln3p regulation, whereas the lst8-1
mutant had a stronger defect in Gln3p but not in Rtg1/3p
regulation (Table II and Table III). Unlike rapamycin treat-
ment, which strongly affects both Rtg1/3p and Gln3p si-
multaneously, the lst8-1 and lst8-6 mutations disrupted one
branch of the regulation more strongly than the other.
To test whether other lst8 alleles show genetically dis-
tinct interactions with the Rtg1/3p and Gln3p pathways,
we isolated additional lst8 temperature-sensitive alleles
by PCR mutagenesis and performed PCIT2-LacZ reporter
assays in glutamate and PGAP1-LacZ reporter assays in glu-
tamine. All mutants were sequenced and represent inde-
pendent alleles with 1–4 missense mutations each (unpub-
lished data). We found that, like lst8-6, the lst8-8, lst8-9,
lst8-11, lst8-13, and lst8-16 mutants showed strong defects
in Rtg1/3p regulation, but only modest defects in Gln3p
regulation (Table V). In contrast, the lst8-15 mutant
showed a modest defect in Rtg1/3p regulation, but a
stronger defect in Gln3p regulation. Thus, lst8 alleles ap-
pear to differentially affect the Rtg1/3p and Gln3p tran-
scription pathways, suggesting that Lst8p may be the com-
ponent that transduces the different outputs of the Tor1/
2p complex.
Localization of Lst8p
We examined the localization of Lst8p by fractionation of
lysates from a strain containing an integrated, fully func-
tional HA-LST8. By differential centrifugation, most Lst8p
sedimented after centrifugation at both 13,000  g and
100,000  g, suggesting that Lst8p is membrane associated
(Fig. 8 A). To determine conditions for extraction of Lst8p
from the insoluble fraction, we treated cell extracts with de-
tergent (1% Triton X-100), high pH, or chaotropic agents
such as salt or urea. Lst8p was extracted to the soluble frac-
tion very efficiently by urea and to a lesser extent by high pH
or high salt, indicating that Lst8p was peripherally associated
with membranes (Fig. 8 B).
To confirm the membrane association of Lst8p, we per-
formed flotation gradients to separate soluble proteins and
proteinaceous complexes, which remain at the bottom of
the gradient, from membrane-associated proteins, which
rise to the isopycnic region of the gradient. Membranes
from a crude lysate were collected by centrifugation at
100,000 g, layered at the bottom of a continuous 30–50%
(wt/wt) sucrose gradient, and centrifuged at 100,000 g for
17 h. Membrane-associated Lst8p was found mainly in
fractions 3–6, cofractionating with GDPase and Pep12p,
the Golgi and endosomal membrane marker proteins (Fig.
8 C). The less dense peak from fractions 5–7 of the trans-
Golgi marker Kex2p, which was shown previously to frac-
tionate in two peaks (Cunningham and Wickner, 1989),
and the vacuole marker protein Vph1p both partially over-
lapped with the peak of Lst8p. The large pool of Lst8p
in fraction 16, which cofractionated with the cytosolic
marker protein Pgk1p (unpublished data), may originate
from Lst8p that exists in a large protein complex that sedi-
ments at 100,000 g. Alternatively, the Lst8p in fraction 16
may have dissociated from membranes during lysate prep-
aration or fractionation. It is unlikely that the Lst8p in
fraction 16 represents a plasma membrane localization be-
cause Lst8p is still found in fraction 16 in flotation experi-
ments with continuous 20–60% sucrose gradients, in
which the plasma membrane is found in fractions 12–15
(unpublished data).
We also used fluorescence microscopy to examine Lst8p
localization. A GFP–Lst8p fusion, which complements an
lst8  mutation, was localized to discrete bodies, some adja-
cent to the vacuole (Fig. 8 D), consistent with the cofrac-
tionation of Lst8p with Golgi and endosomal membranes.
Figure 6. Tor1p and Tor2p associate with Lst8p. A wild-type 
strain with integrated LST8-myc from its own promoter (CKY783; 
lanes 1, 3, 4, and 6) or untagged LST8 (CKY8; lanes 2 and 5) was 
transformed with pRS316 containing HA-TOR1 (pEC267; lanes 1 
and 2), TOR1 (pEC262; lane 3), HA-TOR2 (pEC268; lanes 4 and 5), 
or TOR2 (pEC263; lane 6). Strains were grown in SMM-uracil at 
30 C. Anti-myc (rabbit 9E10) immunoprecipitates (A) or cell lysates 
(B) were subjected to SDS-PAGE and Western blotting with either 
HA (12CA5) or myc (monoclonal 9E10) antibody.
Table V. PCIT2-LacZ and PGAP1-LacZ reporter assays with additional 
lst8 mutants
Strain
PCIT2-LacZ expression 
in glutamate medium
PGAP1-LacZ expression 
in glutamate medium
( -galactosidase units) ( -galactosidase units)
WT 1.8   0.1 12.7   0.4
lst8-1 7.4   1.4 35.9   5.8
lst8-6 245.7   16.1 14.6   1.5
lst8-7 90.2   7.6 31.3   2.5
lst8-8 161.2   3.7 20.7   1.6
lst8-9 113.2   13.2 26.3   2.8
lst8-11 181.4   23.7 24.2   3.0
lst8-13 181.7   28.4 21.7   3.0
lst8-15 7.0   1.4 105.8   13.7
lst8-16 183.6   14.2 29.0   5.7
Strains were ura3-52 (CKY772), lst8-1 ura3-52 (CKY773), lst8-6 ura3-52
(CKY774), lst8-7 ura3-52 (CKY775), lst8-8 ura3-52 (CKY788), lst8-9 ura3-52
(CKY789), lst8-11 ura3-52 (CKY790), lst8-13 ura3-52 (CKY791), lst8-15
ura3-52 (CKY792), and lst8-16 ura3-52 (CKY793), containing pEC261 for
PCIT2-LacZ or pMS29 for PGAP1-LacZ.T
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We performed flotation gradients with a strain coexpress-
ing HA-Lst8p and HA-Tor1p, and found that HA-Lst8p
and HA-Tor1p cofractionate with each other (Fig. 8 E). The
peak of Tor1p in fractions 3–6 is broader than the Lst8p
peak, perhaps indicating that Tor1p is also present on other
membranes that lack Lst8p or that more Tor1p dissociated
from membranes while floating up through the gradient.
Like Lst8p, Tor1p has significant overlap with the endoso-
mal, Golgi, and vacuolar marker proteins Pep12p, GDPase,
and Vph1p (Fig. 8 E). We also tested whether the lst8-1,
lst8-6, and lst8-7 mutations changed the fractionation pat-
tern of Tor1p in these flotation gradients, but found no sig-
nificant effect (unpublished data). Thus, Lst8p is a mem-
brane-associated protein that appears to localize to the Golgi
or endosomal compartments with Tor1p.
Discussion
In this paper, we provide genetic and biochemical evidence
that LST8 encodes a positively acting component of the TOR
pathway. Lst8p associates with Tor1p and Tor2p, and is in-
volved in the regulation of Rtg1/3p and Gln3p, and in main-
tenance of cell wall integrity. We can now explain the role of
Lst8p in the regulation of Gap1p sorting by the three distinct
regulatory processes diagramed in Fig. 9: (1) Tor1/2p and
Lst8p act together to negatively regulate both the Rtg1/3p and
Gln3p transcription factors, limiting the synthesis of  -keto-
glutarate, glutamate, and glutamine; (2) inactivation of the
TOR pathway by mutation of LST8 causes an increase in the
intracellular pools of glutamate and glutamine, as well as
the other amino acids derived from glutamate and glutamine;
and (3) because all amino acids can act as a signal to cause
Figure 7. A sublethal concentration of 
rapamycin causes a defect in Gap1p 
sorting to the plasma membrane. Strains 
were grown for 18 h to exponential 
phase in ammonia medium with empty 
drug vehicle or with 5 ng/ml rapamycin. 
(A) Gap1p activity was measured by 
assaying the rate of [
14C]citrulline 
uptake in wild-type (CKY759) and 
gdh1  (CKY762), both containing 
PADH1-GAP1-HA. The absolute Gap1p 
activity of wild-type with no rapamycin 
is 2,864 pmol/min/OD600. (B) The wild-
type strain in A was harvested, and cell 
extracts were subjected to isopycnic 
fractionation on 20–60% sucrose density 
gradients. Pma1p, Dpm1p, and GDPase 
fractionated in a similar manner in the 
presence or absence of rapamycin.T
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Gap1p sorting to the vacuole, mutation of LST8 causes Gap1p
to be sorted to the vacuole. As validation of this model, we
have shown that growth of wild-type cells in a low, sublethal
concentration of rapamycin or that mutation of LST8 pro-
duces an increase in amino acid pools and a consequent de-
crease in Gap1p activity caused by sorting to the vacuole.
The finding that the cell sorts Gap1p to the vacuole when
TOR pathway function is impaired, by a low rapamycin
concentration or by mutation of LST8, elucidates the differ-
ent effects of the TOR pathway on GAP1 transcription and
the sorting of Gap1p. Previously, it was proposed that rapa-
mycin treatment would have all of the effects of nitrogen
starvation and cause both an increase in GAP1 transcription
and Gap1p sorting to the plasma membrane (Beck et al.,
1999). In contrast, here we have shown that rapamycin
causes distinct and separable effects on GAP1 transcription
Figure 8. Lst8p is a peripheral membrane protein that cofractionates with Golgi and endosomal compartments and with Tor1p. (A) A 
cleared cell lysate from a strain with integrated HA-LST8 (CKY784) was fractionated by centrifugation at 13,000 g, then at 100,000 g. 
Compartment markers are as follows: Pep12p, endosome; Pma1p, plasma membrane; Dpm1p, ER; and Pgk1p, cytosol. The exposure time for 
the Pgk1p panel was very short relative to the other panels. (B) A cleared cell lysate from CKY784 was incubated with the treatments shown 
for 1 h at 4 C, then centrifuged for 1 h at 100,000 g. (C) Fractionation of membranes on a flotation gradient shows that HA-Lst8p associates 
with membranes. A cleared cell lysate from CKY784 was centrifuged at 100,000 g for 1 h onto a cushion of 80% (wt/vol) sucrose. The membranes 
were collected and loaded at the bottom of a continuous 30–50% sucrose gradient, and centrifuged at 100,000 g for 17 h. (D) GFP-Lst8p was 
visualized in an lst8  strain containing GFP-LST8 on a centromere plasmid (CKY785). (E) HA-Tor1p–containing membranes cofractionate 
with HA-Lst8p membranes. Membranes from a strain coexpressing HA-LST8 and HA-TOR1 (CKY800) were fractionated as in C.T
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and on Gap1p sorting. We show that a partial inactivation of
TOR with 5 ng/ml rapamycin causes less Gap1p to be sorted
to the plasma membrane, an effect opposite to that of nitro-
gen starvation. Although the transcriptional induction of
genes such as GAP1 and CIT2 caused by high levels of rapa-
mycin occurs rapidly (Beck and Hall, 1999; Cardenas et al.,
1999; Hardwick et al., 1999; Komeili et al., 2000), the effect
of low levels of rapamycin on Gap1p sorting takes place only
after several hours (unpublished data). This delayed effect on
Gap1p sorting presumably corresponds to the time needed
for the cellular amino acid levels to rise through the rapamy-
cin-dependent induction of Rtg1/3p targets such as CIT2.
Recently, a sublethal concentration of rapamycin (10 ng/ml)
was used to inhibit pseudohyphal development in yeast of
the  1278b background in response to nitrogen limitation
(Cutler et al., 2001). For our strains in the S288C back-
ground growing on minimal ammonia medium, we found
that there was only a narrow range of rapamycin concentra-
tions that were not lethal but that had an effect on Gap1p
sorting; below 3 ng/ml, rapamycin had no effect, and at or
above 10 ng/ml, rapamycin caused a significant growth de-
fect (unpublished data). The range was narrower still for
gdh1 , which grows more slowly than wild-type on ammo-
nia medium even in the absence of rapamycin.
How do Lst8p and Tor1/2p act together to regulate Rtg1/
3p and Gln3p activity? Our analysis of a collection of lst8
mutants showed that some alleles had a greater effect on
Rtg1/3p-dependent transcription than on Gln3p-dependent
transcription, whereas other alleles had a greater effect on
Gln3p-dependent transcription (Table V). The qualitatively
different interactions of Lst8p with these two regulatory
pathways imply that Lst8p has two genetically separable
functions; apparently different parts of the Lst8 protein in-
teract with either the Rtg1/3p or Gln3p regulatory path-
ways. This finding suggests that Lst8p is the subunit of the
TOR complex that communicates with the downstream ef-
fectors of the TOR pathway.
The TOR proteins are thought to have two distinct func-
tions. One function, the integration of nutrient signals with
cell growth, can be performed by either Tor1p or Tor2p and
is inhibited by rapamycin treatment. The second function,
the maintenance of the actin cytoskeleton and cell wall in-
tegrity, is unique to Tor2p and is not inhibited by rapamy-
cin (Zheng et al., 1995; Schmelzle and Hall, 2000). Our
finding that lst8 mutants exhibit both the properties of rapa-
mycin-treated cells and the defects in cell wall integrity of
tor2 mutants, and our finding that Lst8p associates with
both Tor1p and Tor2p imply that Lst8p acts with the TOR
gene products to promote both the shared and the Tor2p-
unique function. This result is in agreement with the recent
report that Lst8p is found in two types of TOR complexes,
proposed to fulfill the two different TOR functions (Loe-
with et al., 2002). However, although Loewith et al. (2002)
observed depolarized actin in cells with PGAL1-LST8 after
15 h in glucose, we did not see any actin defects in lst8 mu-
tants at 24 C in ammonia medium (unpublished data), the
same conditions under which we see a strong Gap1p sorting
defect. These results suggest that although complete deple-
tion of Lst8p may eventually cause actin depolarization, the
Gap1p sorting defect we observe in lst8 mutants is not due
to a cytoskeletal defect.
Rtg2p is a positive regulator of Rtg1/3p activity, but
there is conflicting experimental data on the relationship
between Tor–Lst8p and Rtg2p in the regulation of Rtg1/
3p. Powers and colleagues found that inactivation of the
TOR pathway by rapamycin in an rtg2  mutant fails to in-
duce  CIT2 expression by Rtg1/3p, and concluded that
rtg2  is epistatic to TOR inactivation (Komeili et al., 2000;
Dilova et al., 2002). On the other hand, Liu et al. (2001)
found that mutation of lst8 could restore CIT2 expression
to an rtg2  mutant, and therefore concluded that lst8 is
epistatic to rtg2 . Like Liu et al., we found that some lst8
alleles could restore CIT2 expression in an rtg2  back-
ground (Table II), which again suggested that lst8 is epi-
static to rtg2 . One possible explanation for the conflicting
epistasis results with rtg2  is that abrupt inactivation of
TOR by treatment with rapamycin may have a different ef-
fect on the regulatory network controlling Rtg1/3p activity
than constitutive inactivation of TOR complex activity by
an lst8 mutation. We considered the possibility that Rtg2p
Figure 9. A model of how the Tor1/2 and Lst8 
proteins affect amino acid biosynthesis and Gap1p 
sorting. Tor1/2p and Lst8p negatively regulate the 
activity of the Rtg1p and Rtg3p transcription factors, 
decreasing the expression of enzymes responsible 
for  -ketoglutarate synthesis and limiting the 
synthesis of  -ketoglutarate, glutamate, glutamine, 
and the other amino acids. Tor1/2p and Lst8p 
lso negatively regulate the activity of the Gln3p 
transcription factor, decreasing the expression of 
GDH1 and GLN1, further limiting amino acid 
biosynthesis (Mitchell and Magasanik, 1984; 
Daugherty et al., 1993). Thus, mutation of lst8 
or other impairment of Tor1/2p activity (such 
as treatment with a sublethal concentration of 
rapamycin) causes increased amino acid levels, 
which act as a signal for sorting Gap1p to the 
vacuole.T
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might be a general negative regulator of Tor–Lst8p, and
tested for effects of rtg2  mutants on Gln3p-dependent
transcription, a second output of the Tor–Lst8p pathway.
However, we did not observe an effect of a rtg2  muta-
tion on Gln3p activity using a PGAP1-LacZ reporter on
glutamate, indicating that Rtg2p specifically regulates
Rtg1/3p. The existing data regarding Rtg2p is compatible
with a model in which Rtg2p acts as a negative regulator of
Mks1p (Dilova et al., 2002; Sekito et al., 2002), and Rtg2p
and Mks1p act in parallel to Tor–Lst8p to regulate Rtg1/3p
activity (Fig. 9). Clarification of the precise relationship be-
tween Rtg2p and the TOR pathway awaits further bio-
chemical characterization of Rtg2p.
We found that Lst8p is associated with membranes and
appears to localize to the endosomal/Golgi compartments.
Tor1p also cofractionates with Lst8p and with endosomal/
Golgi and vacuolar markers (Fig. 8). Previous studies of
Tor1/2p localization have led to a variety of conclusions
about the identity of the membranes with which Tor is asso-
ciated: Cardenas and Heitman (1995) reported that Tor2p
associates with vacuolar membranes and Kunz et al. (2000)
reported that Tor1p and Tor2p associate with the plasma
membrane and with a second, unidentified membrane com-
partment. Recently, Loewith et al. (2002) reported that a
pool of Lst8p eluted separately from the Tor proteins during
gel filtration of a lysate prepared by agitation with glass
Table VI. Strains (all are isogenic with S288C). All are from this paper unless noted
Strain Genotype Source
CKY8 MAT  ura3-52 leu2-3, 112 Kaiser strain collection
CKY443 MATa prototroph Kaiser strain collection
CKY445 MAT  gap1 ::LEU2 leu2-3, 112 Kaiser strain collection
CKY526 MATa lst8-1 Kaiser strain collection
CKY758 MATa mks1 ::kanMX6 Kaiser strain collection
CKY759 MAT  PADH1-GAP1-HA Kaiser strain collection
CKY762 MATa gdh1 ::kanMX6 PADH1-GAP1-HA Kaiser strain collection
CKY768 MAT  lst8-1 PADH1-GAP1-HA
CKY769 MAT  lst8-1 gdh1 ::kanMX6 PADH1-GAP1-HA
CKY770 MATa lst8-6
CKY771 MATa lst8-7
CKY772 MATa ura3-52
CKY773 MATa lst8-1 ura3-52
CKY774 MATa lst8-6 ura3-52
CKY775 MATa lst8-7 ura3-52
CKY776 MATa mks1 ::kanMX6 ura3-52
CKY777 MATa ure2 ::kanMX6 ura3-52
CKY778 MATa gln3 ::kanMX6
CKY779 MATa GLN3-13xmyc-kanMX6
CKY780 MATa lst8-1 GLN3-13xmyc-kanMX6
CKY781 MATa lst8-7 GLN3-13xmyc-kanMX6
CKY782 MATa lst8-7 gln3 ::URA3 ura3-52
CKY783 MATa LST8-6xmyc ura3-52
CKY784 MAT  3xHA-LST8
CKY785 MAT  lst8 ::HIS3 ura3-52 leu2-3, 112 his3 200 [pEC264]
CKY786 MATa lst8-6 cwh41 ::kanMX4 lys2 0 ura3 0
CKY787 MATa lst8-6 fks1 ::kanMX4
CKY788 MATa lst8-8 ura3-52
CKY789 MATa lst8-9 ura3-52
CKY790 MATa lst8-11 ura3-52
CKY791 MATa lst8-13 ura3-52
CKY792 MATa lst8-15 ura3-52
CKY793 MATa lst8-16 ura3-52
CKY794 MATa tor1 ::kanMX4 ura3-52
CKY795 MAT  rtg2 ::kanMX6 ura3-52
CKY796 MATa rtg2 ::kanMX6 lst8-1 ura3-52
CKY797 MATa rtg2 ::kanMX6 lst8-6 ura3-52
CKY798 MATa rtg2 ::kanMX6 lst8-7 ura3-52
CKY799 MAT  rtg2 ::kanMX6 mks1 ::kanMX6 ura3-52
CKY800 MATa tor1 ::kanMX4 HA-LST8 ura3-52 [pEC267]
Y16864 MAT  tor1 ::kanMX4 his3 1 leu2 0 lys2 0 ura3 0 Euroscarf collection
Y14395 MAT  cwh41::kanMX4 his3 1 leu2 0 lys2 0 ura3 0 Euroscarf collection
Y15251 MAT  fks1 ::kanMX4 his3 1 leu2 0 lys2 0 ura3 0 Euroscarf collectionT
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beads, suggesting that not all the Lst8p is associated with
Tor1/2p or that some Lst8p dissociated from Tor1/2p dur-
ing lysate preparation. Kog1p/mRaptor is also a TOR-asso-
ciated protein with WD-repeats whose association with
TOR is sensitive to nutrient conditions (Hara et al., 2002;
Kim et al., 2002). Thus, Lst8p may act with Tor1/2p and
Kog1p/Raptor as a component of a large complex on endo-
somal/Golgi membranes for sensing intracellular nutrients
and signaling to metabolic pathways.
Materials and methods
Strains, plasmids, and media
The yeast strains used in this work (listed in Table VI) are all in the S288C
background. One characteristic of the S288C background is high Gap1p
and Put4p activity when ammonia is used as a nitrogen source
(Courchesne and Magasanik, 1983). The lst8 ::HIS3 allele was made us-
ing the fusion PCR protocol from the Botstein lab. Complete gene deletions
of GLN3, URE2, and RTG2 were constructed by gene replacement with
the kanMX6 cassette by homologous recombination (Wach et al., 1994).
Tagging of GLN3 with 13xmyc at its COOH terminus was performed by
homologous recombination (Longtine et al., 1998). Yeast strains contain-
ing HA-LST8 and LST8-6xmyc were constructed as follows: plasmid pEC36
contained LST8 flanked by 361 bp of the 5  region and 412 bp of the 3  re-
gion in pRS315. Unique NotI restriction sites were inserted either just after
start or just before stop by site-directed mutagenesis (creating pEC62 and
pEC63), and 3xHA or 3xmyc was inserted creating pEC85 (HA-Lst8) or
pEC70 (Lst8-6xmyc), respectively. Constructs were verified by sequencing
and by complementation of lst8 . The LST8-containing inserts from pEC85
and pEC70 were moved into pRS306 and integrated into CKY772 by two-
step gene replacement. Plasmids used in this work were as follows:
pMS29, a PGAP1-LacZ fusion at codon 53 of GAP1 in a URA3-CEN vector
(Stanbrough and Magasanik, 1995); pEC261, a PCIT2-LacZ fusion after
codon 3 of CIT2 in pRS316; pEC262, TOR1 in pRS316; pEC263, TOR2 in
pRS316; pEC267, HA-TOR1 in pRS316; pEC268, HA-TOR2 in pRS316;
and pEC264, sGFP-LST8 in pRS315. Plasmid pEC261 was constructed by
ligating a PCR fragment containing 390 bp of the CIT2 promoter (that in-
cludes the region required for the transcriptional regulation of CIT2; Liao
and Butow, 1993) and the first three codons of the CIT2 gene, to the LacZ
coding sequence in pRS316. Plasmids pEC262 and pEC263 were con-
structed by gap repair in yeast of cut plasmids containing nucleotides
 499 to  6 of the 5  region and  1 to  361 of the 3  region for TOR1, or
nucleotides  522 to  4 of the 5  region and  20 to  373 of the 3  region
for TOR2. To construct pEC267 and pEC268, unique restriction sites were
inserted after the start codons of TOR1 and of TOR2, and 3xHA was in-
serted by homologous recombination. To construct pEC264, sGFP was li-
gated into the unique NotI site just after the start codon of LST8 in pEC62
(described above). Minimal media containing ammonia, glutamate, or
glutamine as a nitrogen source were prepared as described previously
(Roberg et al., 1997b). Supplemented minimal medium (SMM) was pre-
pared as described previously (Adams et al., 1996).
Isolation and integration of lst8 temperature-sensitive alleles
PCR mutagenesis of the LST8 gene was performed as described previously
(Muhlrad et al., 1992). In brief, the region from 400 bp 5  to LST8 to 247
bp 3  to LST8 was amplified using Taq in the presence of 0.25 mM MnCl2,
and one-fifth the normal concentration of dATP. The PCR fragment and
pEC36 (described above) cut with BsmI were transformed into ECY269 that
is lst8 ::HIS3 ura3-52 leu2-3, 112 his3 200 [LST8 in pRS316]. For the
lst8-6 allele, pEC36 was mutagenized with hydroxylamine as described
previously (Adams et al., 1996) and transformed into ECY269. Transfor-
mants on SMM-leucine plates were replica-plated onto plates with 5-fluo-
roorotic acid, then screened for temperature sensitivity. Plasmids that con-
ferred temperature-sensitive growth were tested by retransformation.
Inserts were ligated into pRS306 for integration at the LST8 locus by two-
step gene replacement.
Assays for amino acid uptake,  -galactosidase, and total amino 
acid content
Strains were cultured to 4–8   10
6 cells/ml, washed twice with nitrogen-
free medium by filtration on a 0.45- m nitrocellulose filter (Millipore), and
amino acid uptake assays were performed as described previously (Roberg
et al., 1997b).  -Galactosidase activity was measured with the permeabi-
lized cell method (Adams et al., 1996). Two independent transformants
were grown at RT (22 C) and assayed in duplicate. Each experiment was
performed 2–5 times with similar results. Total amino acid analysis was
performed as described previously (Chen and Kaiser, 2002).
Immunofluorescence and fluorescence microscopy
Immunofluorescence was performed using standard protocols (Adams et
al., 1996) with the following modifications. PBS   2% BSA was used for
blocking and for diluting antibodies, cells were incubated with primary an-
tibody overnight at 4 C, and samples were washed 15 times after each an-
tibody incubation. Antibodies used were purified monoclonal 9E10
(Zymed Laboratories) and Alexa
® 488–conjugated goat anti–mouse IgG
(Molecular Probes, Inc.). For GFP microscopy, cells were grown in SMM-
leucine media overnight to exponential phase, then Tris-HCl, pH 8.0 was
added to 100 mM and NaN3 was added to 1% for 15 min before viewing
to ensure that GFP was folded and to enhance detection of GFP in acidic
compartments (Bilodeau et al., 2002). Images were collected using a fluo-
rescence microscope (Eclipse E800; Nikon), a digital camera (Hamamatsu
Corporation), and Openlab software (Improvision).
Equilibrium density centrifugation, differential centrifugation, 
and extraction of proteins from the particulate fraction
Protocols are described in Kaiser et al. (2002). For the differential centrifu-
gation and the extraction of proteins from the particulate fraction proto-
cols, cells were lysed by spheroplasting and douncing. Antibodies used
were: mouse anti-HA 16B12 (Covance); mouse anti-HA 12CA5 (BAbCo);
rabbit anti-Pma1p (a gift of S. Losko and R. Kölling, Heinrich-Heine-Uni-
versitat, Düsseldorf, Germany), mouse anti-Dpm1p (Molecular Probes,
Inc.); mouse anti-Pgk1p (Molecular Probes, Inc.); mouse anti-Vph1p (Mo-
lecular Probes, Inc.); and rabbit anti-Pep12p. Anti-Pep12p serum was
made using a standard antibody protocol (Covance) with 6xHis-Pep12p
made from truncated PEP12 in pET24a (a gift of M. Lewis and H. Pelham,
MRC Laboratory of Molecular Biology, Cambridge, UK).
Flotation gradient with Lst8p or Tor1p-containing membranes
Flotation gradients were performed as described previously (Kaiser et al.,
2002), with the following modifications: 3   10
9 cells from a logarithmi-
cally growing culture were harvested by filtration, then washed in ice-cold
de-energizing buffer (50 mM Tris-HCl, pH 7.5, 10 mM NaN3, and 10 mM
KF), and washed in ice-cold STE10 (10% wt/wt sucrose, 10 mM Tris-HCl,
pH 7.5, and 10 mM EDTA, pH 8.0) by centrifugation. Cells were lysed by
agitation with glass beads in 0.75 ml lysis buffer (STE10 with PMSF and
pepstatin). 2.25 ml lysis buffer was added, and the lysate was cleared by
centrifugation at 500 g for 3 min. Membranes were collected by layering 2
ml of the cleared lysate onto a cushion of 0.2 ml STE80 (80% wt/vol su-
crose, 10 mM Tris-HCl, pH 7.5, and 10 mM EDTA) and centrifuging in a
TLS-55 rotor (Beckman Coulter) at 100,000 g for 1 h at 4 C. Membranes
that collected at the interface were combined with enough STE80 to make
the density of the solution equivalent to the density of STE50 (50% wt/wt
sucrose, 10 mM Tris-HCl pH 7.5, and 10 mM EDTA). A volume of mem-
brane solution corresponding to 3   10
8 cells was loaded at the bottom of
a 30–50% (wt/wt) continuous sucrose gradient and centrifuged at 100,000 g
for 17 h with no brake in an SW55Ti rotor (Beckman Coulter). Fractions
were collected manually from the top of the gradient. A portion of each
fraction was subject to TCA precipitation, SDS-PAGE, and Western blot-
ting, or was assayed for GDPase and Kex2p activity as described previ-
ously (Kaiser et al., 2002). Intensity of protein bands on Western blots was
quantitated using the Kodak Image Station 440 imaging system and Kodak
1D software (PerkinElmer).
Immunoprecipitation and immunoblotting 
of Lst8-associated proteins
Cells (10
8) growing logarithmically in SMM-uracil medium were harvested
and washed with ice-cold 50 mM Hepes, pH 7.5, and 10 mM NaN3. Cells
were lysed by agitation with glass beads in Co-IP buffer (20 mM Hepes, pH
6.8, 80 mM potassium acetate, 5 mM magnesium acetate, and 0.5%
CHAPS) with protease inhibitors (1 mM PMSF, 0.5  g/ml leupeptin, 0.7
 g/ml pepstatin, and 2  g/ml aprotinin), then the lysate was diluted to 1 ml
with Co-IP buffer with protease inhibitors. The lysate was cleared by cen-
trifugation at 13,000 g for 3 min, then the supernatant was precleared by
incubation with protein A Sepharose for 30 min at 4 C. A portion of the
precleared lysate was removed as the “total” sample. To the remaining ly-
sate, rabbit anti-myc antibody (9E10, Santa Cruz Biotechnology) was
added and incubated for 2 h at 4 C. Then, Protein A Sepharose was addedT
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and the mixture incubated for 1 h at 4 C. Immunoprecipitates were
washed three times with Co-IP buffer   0.1% CHAPS, and once with de-
tergent-free Co-IP buffer. Immunoprecipitates were solubilized by incuba-
tion in sample buffer for 30 min at 37 C and resolved by SDS-PAGE. Anti-
bodies used for immunoblotting were mouse anti-HA 12CA5 and mouse
anti-myc 9E10 (Covance).
We thank Barbara Karampalas for construction of the lst8 fks1 and lst8
cwh41 strains, the Kaiser lab for helpful discussions and encouragement,
and D.M. Sabatini for communicating unpublished results.
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Note added in proof. In a recent report, T. Powers and colleagues (Weda-
man, K.P., A. Reinke, S. Anderson, J. Yates 3rd, J.M. McCaffery, and T.
Powers. 2003. Mol. Biol. Cell. 14:1204–1220) used immunogold electron
microscopy to colocalize Lst8p and Tor2p to punctate, membranous sites
adjacent to (but distinct from) the plasma membrane and other sites within
the cell. This localization of Tor/Lst8 is consistent with the endosomal/
Golgi localization for Lst8p based on membrane fractionation we report in
this paper.
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